The fact that the scavenger receptor SORT1 is overexpressed in various types of ovarian, endometrial, and other types of cancers, such as breast cancer, further suggests that exploiting this receptor’s internalization functions could be used in other clinical indications. This evidence concerns the gene SORT1 and breast cancer.